| Financial Year |
March 31 2023 |
| Monetary Funds |
8,022,102,726.90 |
| Held-for-trading Financial Assets |
2,618.20 |
| Notes Receivable |
2,308,182.32 |
| Accounts Receivable |
2,263,563,053.54 |
| Advances to Suppliers |
85,152,012.12 |
| Other Receivables |
133,076,025.30 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
72,000.00 |
| Inventories |
2,808,863,118.20 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
91,106,180.68 |
| Other Current Assets |
293,526,864.50 |
| Total Current Assets |
13,708,557,463.97 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
64,228,158.61 |
| Long-term Equity Investment |
753,423,493.32 |
| Investment Properties |
97,299,611.18 |
| Fixed Assetes |
2,424,421,486.59 |
| Under-construction Projects |
55,257,716.96 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
395,081,172.11 |
| R&D expenses |
1,673,260.51 |
| Goodwill |
622,652,907.24 |
| Long-Term Deferred and Prepaid Expenses |
44,533,867.46 |
| Deferred Income Tax Assets |
23,891,140.32 |
| Other Non-Current Assets |
663,783,319.18 |
| Sub-Total of Non-Current Assets |
7,800,314,448.24 |
| Total Assets |
21,508,871,912.21 |
| Short-Term Loans |
18,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
31,311,607.07 |
| Accounts Payable |
5,763,728,491.54 |
| Accounts Received In Advance |
1,367,577.71 |
| Employee Compensation Payable |
266,765,909.94 |
| Taxes Payable |
69,563,416.31 |
| Interest Payable |
11,152.78 |
| Dividend Payable |
-- |
| Other payables |
442,660,515.73 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
89,636,903.27 |
| Other Current Liabilities |
221,943,208.32 |
| Sub-Total of Current Liabilities |
8,197,702,718.48 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
81,839,085.52 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
441,483,629.14 |
| Total Liabilities |
8,639,186,347.62 |
| Paid-In Capital(Or Share Stock) |
1,233,841,000.00 |
| Capital Surplus |
2,572,524,766.32 |
| Surplus Reserve |
1,154,424,514.15 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
6,283,401,109.86 |
| Minority Stockholder's Interest |
177,025,078.88 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
12,692,660,485.71 |
| Owner's Equity（Stockholder's Equity） |
12,869,685,564.59 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
21,508,871,912.21 |
